The role of interleukin-10 in systemic lupus erythematosus

Journal of Autoimmunity

Volumn 20, Issue 4, 2003, Pages 287-289

  Llorente, Luis ^a   Richaud Patin, Yvonne ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY;

ANTIBODY PRODUCTION; B LYMPHOCYTE; CLINICAL TRIAL; HUMAN; HYPERACTIVITY; IMMUNOGLOBULIN STRUCTURE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0038724264     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-8411(03)00043-X     Document Type: Short Survey

References (26)

1. Klinman D.M., Steinberg A.D. Systemic autoimmune diseases arises from polyclonal B cell activation. J Exp Med. 165:1987;1755-1760.
2. Block S.R., Gibbs C.B., Stevens M.B., Shulman L.E. Delayed hypersensitivity in systemic lupus erythematosus. Ann Rheum Dis. 27:1968;311-318.
3. Via G.S., Tsokos G.C., Bermas B., Clerici M., Shearer G.M. T cell-antigen-presenting cell interactions in human systemic lupus erythematosus: evidence for heterogeneous expression of multiple defects. J Immunol. 151:1993;3914-3922.
4. Rousset F., Garcia E., Defrance T., Peronne C., Hsu D.H., Kastelin R., et al. Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA. 89:1992;1890-1893.
5. De Waal Malefyt R., Yssel H., de Vries J.E. Direct effect of IL-10 on subsets of human CD4+ T cell clones and resting T cells: specific inhibition of IL-2 production and proliferation. J Immunol. 150:1993;4754-4765.
6. Llorente L., Richaud-Patin Y., Wijdenes J., Alcocer-Varela J., Maillot M.C., Durand-Gasselin I., et al. Spontaneous production interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw. 4:1993;421-430.
7. Llorente L., Richaud-Patin Y., Fior R., Alcocer-Varela J., Wijdenes J., Morel-Fourrier B., et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus: a potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum. 37:1994;1647-1655.
8. Hagiwara E., Gourdley M.F., Lee S., Klinman D.M. Disease severity in patients with systemic lupus erythematosus correlates with an increased ration of interleukin-10: interferon-γ-secreting cells in the peripheral blood. Arthritis Rheum. 39:1996;379-385.
9. Horwitz D.A., Gray J.D., Behrendsen S.C., Kubin M., Rengaraju M., Ohtsuka K., et al. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum. 41:1998;838-844.
10. Lacki J.K., Sambroski W., Mackiewicz S.H. Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlation with acute phase proteins. Clin Rheumatol. 16:1997;275-278.
11. Houssiau F.A., Lefebvre C., van den Berghe M., Lambert M., Devogelaer J.P., Renauld J.C. Serum interleukin-10 titers in systemic lupus erythematosus reflect disease activity. Lupus. 4:1995;393-395.
12. Park Y.B., Lee S.K., Kim D.S., Lee J., Lee C.H., Song C.H. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol. 16:1998;283-288.
13. Miles S., Isenberg D. A review of serological abnormalities in relatives of SLE patients. Lupus. 2:1993;145-150.
14. Sakane T., Murakawa Y., Suzuki N., Ueda Y., Tsuchida T., Takada S., et al. Familial occurrence of impaired interleukin-2 activity and increased peripheral blood B cells actively secreting immunoglobulins in systemic lupus erythematosus. Am J Med. 86:1989;385-390.
15. Eksdale J., Wordsworth P., Bowman S., Field M., Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens. 49:1997;635-639.
16. Lazarus M., Hajeer A.H., Turner D., Sinnott P., Worthington J., Ollier W.E., et al. Genetic variation in the interleukin-10 promoter and systemic lupus erythematosus. J Rheumatol. 24:1997;2314-2317.
17. Gröndal G., Kristjansdottir H., Gunnlaugsdottir B., Arnason A., Lundberg I., Klareskog L., et al. Increased number of interleukin-10 producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families. Arthritis Rheum. 42:1999;1649-1654.
18. Gröndal G., Traustadottir K.H., Kristjansdottir H., Lundberg I., Klareskog L., Erlendsson K., et al. Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families. Lupus. 11:2002;435-442.
19. Llorente L., Zou W., Levy Y., Richaud-Patin Y., Wijdenes J., Alcocer-Varela J., et al. Role of interleukin-10 in the B lymphocyte hyperactivity and autoantibody production of systemic lupus erythematosus. J Exp Med. 181:1995;839-844.
20. Levy Y., Brouet J.C. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Invest. 93:1994;424-428.
21. Ullrich S.E. Mechanism involved in the systemic suppression of antigen-presenting cell function by UV irradiation: keratinocyte-derived IL-10 modulates antigen-presenting cell function of splenic adherent cells. J Immunol. 152:1994;3410-3416.
22. Huizinga T.W., van der Linden M.W., Deneys-Laporte V., Breedveld F.C. Interleukin-10 as an explanation for pregnancy-induced flare in systemic lupus erythematosus and remission in rheumatoid arthritis. Rheumatology. 38:1999;496-498.
23. Ishida H., Muchamuel S., Sakaguchi S., Andrade S., Menon S., Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med. 179:1994;305-310.
24. Lauwerys B.R., Garot N., Renauld J.C., Houssiau F.A. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients. Arthritis Rheum. 43:2000;1976-1981.
25. Llorente L., Richaud-Patin Y., Garcia-Padilla C., Claret E., Jakez-Ocampo J., Cardiel M.H., et al. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum. 43:2000;1790-1800.
26. Lipsky P.E. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol. 2:2001;764-766.